Terumo Management

Management criteria checks 1/4

Terumo's CEO is Hikaru Samejima, appointed in Apr 2024, has a tenure of less than a year. directly owns 0.003% of the company’s shares, worth MX$16.01M. The average tenure of the management team and the board of directors is 0.8 years and 3.1 years respectively.

Key information

Hikaru Samejima

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	less than a year
CEO ownership	0.003%
Management average tenure	less than a year
Board average tenure	3.1yrs

Recent management updates

Recent updates

CEO

Hikaru Samejima (60 yo)

less than a year

Tenure

Mr. Hikaru Samejima served as Director of Terumo Corporation since February 7, 2024 until June 26, 2024 and serves as its Representative Director since June 26, 2024. He serves as President and CEO of Teru...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Toshiaki Takagi	Chairman of the Board & Group Managing Executive Officer	14.4yrs	JP¥137.00m	no data
Hikaru Samejima	Representative Director	less than a year	no data	0.0027% MX$ 16.0m
Jin Hagimoto	CFO, CIO	less than a year	no data	no data
Shinji Omori	CTO, GM of DX Promotion Dept. R&D Division and Executive Officer	less than a year	no data	no data
Miho Mizuguchi	Executive Officer	8.6yrs	no data	no data
Tomoko Adachi	Chief Human Resources Officer & Group Executive Officer	1.8yrs	no data	no data
Kazunori Hirose	Director & Group Managing Executive Officer	no data	no data	0.0023% MX$ 13.6m
Itaru Sakaguchi	Group Managing Executive Officer	less than a year	no data	no data
Toshihiko Osada	Group Senior Managing Executive Officer & Director	no data	no data	no data
Fumihisa Hirose	Group Managing Executive Officer	less than a year	no data	no data
Norimasa Kunimoto	Director & Group Managing Executive Officer	1.6yrs	no data	0.0026% MX$ 15.8m
Antoinette Gawin	Group Senior Managing Executive Officer	less than a year	no data	no data

0.8yrs

Average Tenure

60.5yo

Average Age

Experienced Management: 4543 N's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.

Board Members

Name	Position	Tenure	Compensation	Ownership
Toshiaki Takagi	Chairman of the Board & Group Managing Executive Officer	14.4yrs	JP¥137.00m	no data
Hikaru Samejima	Representative Director	less than a year	no data	0.0027% MX$ 16.0m
Kazunori Hirose	Director & Group Managing Executive Officer	2.8yrs	no data	0.0023% MX$ 13.6m
Toshihiko Osada	Group Senior Managing Executive Officer & Director	less than a year	no data	no data
Norimasa Kunimoto	Director & Group Managing Executive Officer	1.4yrs	no data	0.0026% MX$ 15.8m
Soichiro Uno	Independent Director	5.4yrs	no data	no data
Hidenori Nishi	Independent Outside Director	4.4yrs	no data	0.00029% MX$ 1.7m
Takanori Shibazaki	Director	3.4yrs	no data	0.0025% MX$ 14.9m
Koichi Sakaguchi	Substitute Director	2.4yrs	no data	no data
Masaichi Nakamura	Independent Outside Director	5.4yrs	no data	0.00037% MX$ 2.2m
Keiya Ozawa	Independent Outside Director	3.4yrs	no data	0.00011% MX$ 662.0k
Mari Kogiso	Independent Director	less than a year	no data	no data

3.1yrs

Average Tenure

63yo

Average Age

Experienced Board: 4543 N's board of directors are considered experienced (3.1 years average tenure).

Terumo Management

Management criteria checks 1/4

Key information

Recent management updates

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Terumo Corporation, Annual General Meeting, Jun 26, 2024

Less than half of directors are independent

Terumo Corporation, Annual General Meeting, Jun 27, 2023

Recent updates

Second quarter 2025 earnings released: EPS: JP¥19.74 (vs JP¥18.49 in 2Q 2024)

Less than half of directors are independent

Terumo Corporation to Report Q2, 2025 Results on Nov 07, 2024

Terumo Corporation (TSE:4543) announces an Equity Buyback for 15,000,000 shares, representing 1.01% for ¥30,000 million.

Terumo Corporation to Report Q1, 2025 Results on Aug 08, 2024

Terumo Cardiovascular Announces 510(K) Clearance for the CDI Oneview™? Monitoring System

Full year 2024 earnings released: EPS: JP¥71.50 (vs JP¥59.50 in FY 2023)

Less than half of directors are independent

Less than half of directors are independent

Terumo Corporation to Report Fiscal Year 2024 Results on May 14, 2024

Terumo Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024

Terumo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024

Terumo Corporation, Annual General Meeting, Jun 26, 2024

Terumo Corporation to Report Q3, 2024 Results on Feb 07, 2024

Terumo Corporation to Report Q2, 2024 Results on Nov 14, 2023

Terumo Corporation (TSE:4543) announces an Equity Buyback for 5,000,000 shares, representing 0.67% for ¥20,000 million.

Less than half of directors are independent

Terumo Corporation to Report Q1, 2024 Results on Aug 09, 2023

Terumo Corporation Announces Fiscal Year-End Dividend for the Fiscal Year Ended March 31, 2023, Payable on June 28, 2023; Provides Second Quarter-End Dividend Guidance for the Fiscal Year Ending March 31, 2024 and Provides Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024

Terumo Corporation, Annual General Meeting, Jun 27, 2023

Less than half of directors are independent

Less than half of directors are independent

Third quarter 2023 earnings released: EPS: JP¥39.97 (vs JP¥28.70 in 3Q 2022)

Terumo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Terumo Corporation Announces Dividend for the Second Quarter End of Fiscal Year 2023, Commences Dividend Payments on December 5, 2022; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2023

Terumo Corporation to Report Q3, 2023 Results on Nov 10, 2023

Less than half of directors are independent

Terumo Corporation to Report Q2, 2023 Results on Nov 10, 2022

Mitsui DM Sugar Holdings Co.,Ltd. (TSE:2109) agreed to acquire Enteral formula business of Terumo Corporation from Terumo Corporation (TSE:4543).

NUTRI Co.,Ltd. entered into an agreement to acquire Nutritional food and related product assets of Terumo Corporation.

First quarter 2023 earnings released: EPS: JP¥29.61 (vs JP¥36.90 in 1Q 2022)

Terumo Corporation Provides Dividend Guidance for the Second Quarter of Year Ending March 31, 2023

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Terumo Announces Change in Indication for Dexcom G6 CGM System in Japan

Terumo Corporation (TSE:4543) announces an Equity Buyback for 15,000,000 shares, representing 1.98% for ¥50,000 million.

Less than half of directors are independent

Terumo Corporation to Report Fiscal Year 2022 Results on May 12, 2022

Upcoming dividend of JP¥16.00 per share

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Terumo Corporation, Annual General Meeting, Jun 22, 2022

Terumo Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2022

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Second quarter 2022 earnings released: EPS JP¥29.22 (vs JP¥23.63 in 2Q 2021)

Less than half of directors are independent

Less than half of directors are independent

CEO

Tenure

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age